HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

How I approach hereditary hemolytic anemia and splenectomy.

Abstract
Hereditary hemolytic anemias (HHA) are a heterogeneous group of anemias associated with decreased red cell survival. While there can be clinical benefit of splenectomy in many cases, splenectomy is not appropriate for all types of HHA. Additionally, there are significant risks during and following splenectomy including surgical risks, postsplenectomy sepsis, and thrombotic complications. This review discusses the diagnostic approach to HHA as well as the role of splenectomy in the management. Surgical approaches and outcomes for total and partial splenectomy are discussed.
AuthorsJennifer A Rothman, Jenny L Stevens, Fabienne L Gray, Theodosia A Kalfa
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 67 Issue 11 Pg. e28337 (11 2020) ISSN: 1545-5017 [Electronic] United States
PMID32391969 (Publication Type: Case Reports, Journal Article)
Copyright© 2020 Wiley Periodicals, Inc.
Topics
  • Adolescent
  • Anemia, Hemolytic, Congenital (pathology, surgery)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Postoperative Complications (etiology, prevention & control)
  • Prognosis
  • Referral and Consultation
  • Splenectomy (adverse effects, methods, standards)
  • Thrombosis (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: